2026 American Academy of Neurology Abstract Website

Disclosures for "Emgality Transfer into Breast Milk"

Dr. Udawatta has nothing to disclose.
Ms. Kim has nothing to disclose.
Mrs. Bertrand has nothing to disclose.
Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmamark. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Focus MedEd. Dr. Ehrlich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNeura. Dr. Ehrlich has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axome Therapeutics. Dr. Ehrlich has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ehrlich has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurology Advanced Practice Providers. Dr. Ehrlich has a non-compensated relationship as a Board President with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Dr. Ehrlich has a non-compensated relationship as a Board President with The Headache Alliance that is relevant to AAN interests or activities. Dr. Ehrlich has a non-compensated relationship as a Advanced Practice Provider Board Liaison with American Headache Society that is relevant to AAN interests or activities.
Miss Balan has nothing to disclose.
An immediate family member of Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Headache Society. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of an immediate family member of Dr. Gelfand has received research support from Hoffman LaRoche. The institution of an immediate family member of Dr. Gelfand has received research support from Vigil Neuroscience. The institution of an immediate family member of Dr. Gelfand has received research support from NIH/NINDS. The institution of Dr. Gelfand has received research support from PCORI. The institution of Dr. Gelfand has received research support from UCSF RAP grant. Dr. Gelfand has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Weill Cornell Neurology Department. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Taiwan Headache Society. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Author with Elsevier. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with College Board SSD. Dr. Gelfand has received personal compensation in the range of $0-$499 for serving as a Speaker with Kobenhavns Unversitet. An immediate family member of Dr. Gelfand has a non-compensated relationship as a Clinical Trial Steering Committee Member with Roche/Genentech that is relevant to AAN interests or activities.
Author has nothing to disclose
Ms. Chambers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Baylor Genetics. Ms. Chambers has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Muscular Dystrophy Association.
Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.